Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Exxon Mobil
XOM
|
+$525M |
| 2 |
Apple
AAPL
|
+$396M |
| 3 |
Johnson & Johnson
JNJ
|
+$358M |
| 4 |
Microsoft
MSFT
|
+$335M |
| 5 |
Procter & Gamble
PG
|
+$295M |
Top Sells
Sector Composition
| 1 | Technology | 12.81% |
| 2 | Healthcare | 12.33% |
| 3 | Energy | 11.94% |
| 4 | Consumer Staples | 11.16% |
| 5 | Industrials | 10.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BOBE
1301
DELISTED
Bob Evans Farms, Inc.
BOBE
| $1.18M | 0.01% |
+25,200
| New | +$1.18M |
|
|
ESND
1302
DELISTED
Essendant Inc.
ESND
| $1.18M | 0.01% |
+35,200
| New | +$1.18M |
|
1303
First Majestic Silver
AG
$5.15B
| $1.18M | 0.01% |
+111,000
| New | +$1.18M |
|
|
LTC
1304
LTC Properties
LTC
$1.67B
| $1.18M | 0.01% |
+30,200
| New | +$1.18M |
|
1305
Hecla Mining
HL
$7.51B
| $1.18M | 0.01% |
+394,215
| New | +$1.18M |
|
|
VSI
1306
DELISTED
Vitamin Shoppe Inc.
VSI
| $1.18M | 0.01% |
+26,200
| New | +$1.18M |
|
|
WW
1307
DELISTED
WW International
WW
| $1.17M | 0.01% |
+25,500
| New | +$1.17M |
|
|
CLNY
1308
DELISTED
Colony Capital, Inc.
CLNY
| $1.17M | 0.01% |
+58,900
| New | +$1.17M |
|
1309
Franklin Electric
FELE
$4.21B
| $1.17M | 0.01% |
+34,800
| New | +$1.17M |
|
1310
Nektar Therapeutics
NKTR
$926M
| $1.17M | 0.01% |
+6,760
| New | +$1.17M |
|
|
CONN
1311
DELISTED
Conn's Inc.
CONN
| $1.17M | 0.01% |
+22,600
| New | +$1.17M |
|
1312
Universal Corp
UVV
$1.38B
| $1.17M | 0.01% |
+20,200
| New | +$1.17M |
|
1313
American Axle
AXL
$697M
| $1.17M | 0.01% |
+62,700
| New | +$1.17M |
|
|
MDC
1314
DELISTED
M.D.C. Holdings, Inc.
MDC
| $1.17M | 0.01% |
+49,859
| New | +$1.17M |
|
1315
Armstrong World Industries
AWI
$8.5B
| $1.17M | 0.01% |
+24,400
| New | +$1.17M |
|
1316
Mercury Insurance
MCY
$4.4B
| $1.17M | 0.01% |
+26,500
| New | +$1.17M |
|
1317
Spire
SR
$4.49B
| $1.16M | 0.01% |
+25,500
| New | +$1.16M |
|
1318
Tronox
TROX
$767M
| $1.16M | 0.01% |
+57,700
| New | +$1.16M |
|
1319
Celldex Therapeutics
CLDX
$1.62B
| $1.16M | 0.01% |
+4,960
| New | +$1.16M |
|
1320
Westamerica Bancorp
WABC
$1.24B
| $1.16M | 0.01% |
+25,400
| New | +$1.16M |
|
|
INFN
1321
DELISTED
Infinera Corporation Common Stock
INFN
| $1.16M | 0.01% |
+108,800
| New | +$1.16M |
|
|
ACOR
1322
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $1.16M | 0.01% |
+293
| New | +$1.16M |
|
|
SVU
1323
DELISTED
SUPERVALU Inc.
SVU
| $1.16M | 0.01% |
+26,614
| New | +$1.16M |
|
|
AEGR
1324
DELISTED
Aegerion Pharmaceuticals, Inc.
AEGR
| $1.16M | 0.01% |
+18,300
| New | +$1.16M |
|
1325
Entegris
ENTG
$13.2B
| $1.16M | 0.01% |
+123,300
| New | +$1.16M |
|